Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

Add To Watchlist

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Plasminogen Improves Lung Lesions and Hypoxemia

View:

Post by Biostocks01 on Mar 19, 2020 11:07pm

Plasminogen Improves Lung Lesions and Hypoxemia

Plasminogen Improves Lung Lesions and Hypoxemia in Patients with COVID-19

https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3552628

Bio

144

Comment

Comment by stockbuphoon on Mar 19, 2020 11:28pm

just imagine if Pierre had have taken the conservative approach to CMC and hired consultants in 2015 and Ryplazim was approved in 2018, they would be pumping Ryplazim into COVID19 lungs right now. Maybe trump or others might see the potential under these desperate times. Give LMNL a billion to produce as much Pg as possible? Dreaming but who knows if this pandemic gets out of control

Comment

Comment by GoBBs on Mar 19, 2020 11:36pm

Nice info ... and not surprising to many of us that invested in this company ages ago..we were expecting great things from PLI but instead TV decided to squash us. Maybe the FDA will approve Ryplazim sooner and allow them to apply it to COVID patients to expedite healing ...Too bad TV owns it but were not done fighting these people ...

Comment